Great Lakes Advisors’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-503
Closed -$207K 876
2024
Q2
$207K Sell
503
-3,994
-89% -$1.58M ﹤0.01% 801
2024
Q1
$1.82M Sell
4,497
-114
-2% -$40.1K 0.02% 481
2023
Q4
$1.41M Sell
4,611
-5,185
-53% -$1.4M 0.01% 495
2023
Q3
$2.37M Sell
9,796
-736
-7% -$188K 0.02% 437
2023
Q2
$2.53M Sell
10,532
-24,500
-70% -$5.09M 0.03% 426
2023
Q1
$6.59M Buy
35,032
+26,717
+321% +$5.53M 0.06% 300
2022
Q4
$1.77M Sell
8,315
-6,665
-44% -$1.33M 0.1% 315
2022
Q3
$2.35M Buy
14,980
+1,804
+14% +$288K 0.05% 327
2022
Q2
$1.97M Sell
13,176
-127
-1% -$18.4K 0.04% 368
2022
Q1
$2.18M Buy
13,303
+3,983
+43% +$657K 0.04% 366
2021
Q4
$2.03M Buy
9,320
+341
+4% +$71.4K 0.03% 383
2021
Q3
$1.7M Hold
8,979
0.03% 399
2021
Q2
$1.59M Sell
8,979
-851
-9% -$147K 0.02% 416
2021
Q1
$1.61M Sell
9,830
-1,842
-16% -$282K 0.03% 412
2020
Q4
$1.63M Sell
11,672
-123
-1% -$15.5K 0.03% 384
2020
Q3
$1.32M Sell
11,795
-3,971
-25% -$459K 0.03% 382
2020
Q2
$1.47M Buy
15,766
+7,358
+88% +$626K 0.04% 367
2020
Q1
$617K Buy
+8,408
New +$730K 0.02% 415

Other funds holding MEDP

Great Lakes Advisors's MEDP Position: Q3 2024 in Review

Great Lakes Advisors sold out of Medpace (MEDP) in Q3 2024, closing a stake of 503 shares — an estimated $207K sold.

Great Lakes Advisors first reported a position in MEDP in Q1 2020 and held it in 18 quarters. The position peaked at $6.59M in Q1 2023. 583 funds tracked by Wall St. Rank hold MEDP as of Q3 2024.

  • Great Lakes Advisors reported no remaining Medpace position as of Q3 2024 after selling out during the quarter.
  • Great Lakes Advisors sold 503 Medpace shares in Q3 2024, an estimated $207K.
  • Great Lakes Advisors first reported a position in Medpace in Q1 2020 and held it in 18 quarters.
  • Great Lakes Advisors's Medpace position peaked at $6.59M in Q1 2023.
  • 583 funds tracked by Wall St. Rank held Medpace as of Q3 2024.

Based on Great Lakes Advisors's 13F filing for Q3 2024, filed 4 Nov 2024.